Neonatal Group B streptococcal disease: How infection control teams can contribute to prevention efforts

Infection Control and Hospital Epidemiology

Volumn 21, Issue 7, 2000, Pages 473-483

  Schrag, Stephanie J ^a   Whitney, Cynthia G ^a   Schuchat, Anne ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIONITIS; DISEASE CONTROL; FEMALE; FETUS; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEWBORN; PRACTICE GUIDELINE; PRENATAL SCREENING; PUERPERAL INFECTION; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

EID: 0033853026     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501791     Document Type: Review

References (57)

1. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973;82:724-729.
2. Barton LL, Feigin RD, Lins R. Group B beta hemolytic streptococcal meningitis in infants. J Pediatr 1973;82:719-723.
3. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-718.
4. McCracken GH. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973;82:703-706.
5. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1996;77:604-610.
6. McDonald H, Vigneswaran R, O'Loughlin JA. Group B streptococcal colonization and preterm labor. Aust N Z J Obstet Gynecol 1989;29:291-293.
7. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-1669.
8. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic approach. JAMA 1993;270:1442-1448.
9. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-494.
10. Yancey MK, Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;83:367-371.
11. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999;103:703-710.
12. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics 1997;99:489-496.
13. Committee on Obstetric Practice American College of Obstetricians and Gynecologists. Prevention of Early-Onset Group B Streptococcal Disease in Newborns. Washington, DC: American College of Obstetricians and Gynecologists; 1996.
14. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(RR-7):1-24.
15. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998;11:497-513.
16. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Leftkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
17. Anthony BF, Okada DM. The emergence of group B streptococci in infections of the newborn infant. Annu Rev Med 1977;28:355-369.
18. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-677.
19. Wald ER, Bergman I, Taylor HG, Chiponis D, Porter C, Kubek K, et al. Long-term outcome of group B streptococcal meningitis. Pediatrics 1986;77:217-221.
20. Edwards MS, Rench MA, Haffar AA, Murphy MA, Desmond MM, Baker CJ. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 1985;106:717-722.
21. Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982;145:794-799.
22. Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring, I: colonization studies. Am J Obstet Gynecol 1980;137:34-38.
23. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein O, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, PA: WB Saunders; 1995:980-1054.
24. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease, I: epidemiologic rationale. J Infect Dis 1983;148:795-801.
25. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 1992;41:25-32.
26. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991;77:604-610.
27. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31-36.
28. Schuchat A. Group B streptococcus. Lancet 1999;353:51-56.
29. Robbins JB, Schneerson R, Vann WF, Bryla DA, Fattom A. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann NY Acad Sci 1995;754:68-82.
30. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA Hickman ME, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-150.
31. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease - United States, 1997. MMWR 1998;47:665-670.
32. Lieu TA, Mohle-Boetani JC, Ray T, Ackerson LM, Walton DL. Neonatal group B streptococcal infection in a managed care population. Obstet Gynecol 1998;92:21-27.
33. Davis RL, Hasselquist MB, Zerr DM, Schuchat A. Introduction of the new CDC group B streptococcal prevention guideline at a large West Coast health maintenance organization. Presented at the Pediatric Academic Societies Conference; May 1999; San Francisco, CA. Abstract 105.
34. Factor SH, Whitney CG, Zywicki SS, Schuchat A. Effects of hospital policies based on 1996 group B streptococcal consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol 2000;95:377-382.
35. Towers CV, Suriano K, Asrat T. The capture rate of at-risk term new-borns for early-onset group B streptococcal sepsis determined by a risk factor approach. Am J Obstet Gynecol 1999;181:1243-1249.
36. Rosenstein NE, Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol 1997;90:901-906.
37. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-815.
38. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995;85:437-439.
39. Badri MS, Zawaneh S, Cruz AC, Mantilla G, Baer H, Spellacy WN, et al. Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis 1977;135:308-312.
40. Sayahtaheri Altaie S, Dryja D. Detection of group B streptococcus: comparison of solid and liquid culture media with and without selective antibiotics. Diagn Microbiol Infect Dis 1994;18:141-144.
41. Centers for Disease Control and Prevention. Laboratory practices for prenatal group B streptococcal screening and reporting - Connecticut, Georgia and Minnesota, 1997-1998. MMWR 1999;48:426-428.
42. Heim K, Alge A, Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet 1991;337:859-860.
43. McDuffie RS, McGregor JA Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcal carriage. Obstet Gynecol 1993;82:487-489.
44. Amstey MS, Gibbs RS. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol 1994;84:1058-1059.
45. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-1519.
46. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-261.
47. National Committee for Clinical Laboratory Standards. Approved Standard M7-A4: Standard Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Wayne, PA: NCCLS; 1997.
48. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-883.
49. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998;152:35-40.
50. Isaacs D, Royle JA. Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia. Pediatr Infect Dis J 1999;18:524-528.
51. Adams WG, Kinney JS, Schuchat A, Collier CL, Papasian CJ, Kilbride HW, et al. Outbreak of early-onset group B streptococcal sepsis. Pediatr Infect Dis J 1993;12:565-570.
52. Takayanagi T, Tanaka H, Yoshinaga M, Aoki M, Teshima H, Fukuda M, et al. An outbreak of group B streptococcus in a neonatal nursery and subsequent trial for prophylaxis of nosocomial transmission. Acta Paediatr Jpn 1994;36:88-90.
53. Noya FJD, Rench MA, Metzger TG, Colman G, Naidoo J, Baker CJ. Unusual occurrence of an epidemic of type 1b/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987;155:1135-1144.
54. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000;105(1 Pt 1):21-26.
55. Queenan JT. GBS prevention: national guidelines at last. Contemp Obstet Gynecol 1996;41:8-11.
56. Kramarow E, Letzner H, Rooks R, Weeks J. Health and Aging Chartbook: Health, United States, 1999. Hyattsville, MD: National Center for Health Statistics; 1999.
57. Towers CV, Rumney PJ, Minkiewicz SF, Asrat T. Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: a prospective study. Am J Obstet Gynecol 1999;181:1197-1202.